PlexusDx recommends working closely with your provider before, during, and after any changes to GLP-1 therapy
Sirtuin functions in health and disease
Obese patients, have been reported to produce more SCFAs in their intestines (310), but indeed meaningful diet-induced shifts in SCFA production fluxes have proven not sufficient to modulate peripheral levels of GLP-1 and PYY (311)
B., Thompson, J
Even if small amounts did enter milk, they would likely be broken down in the infants digestive tract , just like other proteins naturally present in breast milk
Regulatory compliance requirements vary by region, with different markets requiring specific certifications, testing documentation, and quality standards for imported pharmaceutical raw materials